A Study of Fostamatinib in Subjects With Impaired Hepatic (Liver) Function

Clinical trial NCT01222455 · COMPLETED

Trial details

NCT number: NCT01222455
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment Healthy Volunteers Pharmacokinetics Amount of R406 in Blood

Start date: 2010-10-01
Primary completion: 2011-06-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.